Healixa Inc.
EMOR · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6,688.5% | – | -100% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 35.2% | -275.3% | – | -83.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,055.4% | -5,916.8% | – | -25,166.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,123.8% | -7,316.1% | – | -25,329.4% |
| EPS Diluted | -0.009 | -0.001 | -0.004 | -0.019 |
| % Growth | -987.5% | 77.1% | 81.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |